(Q34454908)

2 August 2017

0 references

Circulating microRNA-21 as a biomarker for the detection of various carcinomas: an updated meta-analysis based on 36 studies (English)

1 reference

2 August 2017

0 references

0 references

1 reference

Kailiu Wu

1

1 reference

2 August 2017

Liwen Li

series ordinal

2

1 reference

2 August 2017

Siyi Li

series ordinal

3

1 reference

2 August 2017

publication date

20 December 2014

1 reference

2 August 2017

1 reference

2 August 2017

volume

36

1 reference

2 August 2017

issue

3

1 reference

2 August 2017

page(s)

1973-1981

1 reference

2 August 2017

cites work

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2803-2

21 January 2018

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2803-2

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2803-2

CA19.9 antigen circulating in the serum of colon cancer patients: where is it from?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2803-2

The advantage of circulating tumor cells over serum carcinoembryonic antigen for predicting treatment responses in rectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2803-2

Diagnostic and prognostic implications of a serum miRNA panel in oesophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2803-2

MicroRNAs: small RNAs with a big role in gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2803-2

MicroRNA-21: a therapeutic target for reversing drug resistance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2803-2

MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2803-2

MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2803-2

Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2803-2

A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2803-2

Potential role of microRNA-21 in the diagnosis of gastric cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2803-2

Serum microRNA-21 as a diagnostic marker for lung carcinoma: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2803-2

Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2803-2

Multivariate random effects meta-analysis of diagnostic tests with multiple thresholds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2803-2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2803-2

Plasma microRNAs as potential biomarkers for non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2803-2

Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2803-2

The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2803-2

Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2803-2

Differential microRNAs expression in serum of patients with lung cancer, pulmonary tuberculosis, and pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2803-2

Plasma miR-21 is a novel diagnostic biomarker for biliary tract cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2803-2

Serum miR-21 and miR-92a as biomarkers in the diagnosis and prognosis of colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2803-2

Diagnostic and prognostic value of plasma microRNA deregulation in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2803-2

Identification and evaluation of plasma microRNAs for early detection of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2803-2

Serum circulating microRNA profiling for identification of potential breast cancer biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2803-2

Circulating microRNAs as specific biomarkers for breast cancer detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2803-2

Identification of serum miRNAs as novel non-invasive biomarkers for detection of high risk for early gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2803-2

Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2803-2

Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2803-2

Serum miR-21 is a diagnostic and prognostic marker of primary central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2803-2

Circulating miR-378 in plasma: a reliable, haemolysis-independent biomarker for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2803-2

Clinical significance of serum miR-21 in breast cancer compared with CA153 and CEA

21 January 2018

1 reference

12 December 2020

Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer

1 reference

12 December 2020

Quantification of Plasma miRNAs by Digital PCR for Cancer Diagnosis

1 reference

12 December 2020

Detection of lung cancer with blood microRNA-21 expression levels in Chinese population

1 reference

12 December 2020

[Diagnostic values of salivary versus and plasma microRNA-21 for early esophageal cancer].

1 reference

12 December 2020

Diagnostic value of microRNA-21 in the diagnosis of lung cancer: evidence from a meta-analysis involving 11 studies

1 reference

12 December 2020

Plasma and EBC microRNAs as early biomarkers of non-small-cell lung cancer

1 reference

12 December 2020

Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis

1 reference

12 December 2020

A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer

1 reference

12 December 2020

Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients

1 reference

12 December 2020

miR-1254 and miR-574-5p: Serum-Based microRNA Biomarkers for Early-Stage Non-small Cell Lung Cancer

1 reference

12 December 2020

MicroRNA-21 is a new marker of circulating tumor cells in gastric cancer patients

1 reference

12 December 2020

Plasma miR-21: a potential diagnostic marker of colorectal cancer

1 reference

12 December 2020

Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma

1 reference

12 December 2020

Plasma microRNA-320, microRNA-let-7e and microRNA-21 as novel potential biomarkers for the detection of retinoblastoma

1 reference

12 December 2020

Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis

1 reference

12 December 2020

MicroRNA biomarkers in whole blood for detection of pancreatic cancer

1 reference

12 December 2020

10.1007/S13277-014-2803-2

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

1010191573

0 references

1 reference